Ready to upload
Adverse Occurrence type:
Case report. Patient with systemic lupus erythematosus treated with fludarabine.
Time to detection:
Alerting signals, symptoms, evidence of occurrence:
Fever, skin rash, pancytopenia, increased bilirubin, abnormal liver function tests.
Demonstration of imputability or root cause:
Marrow biopsy showed severe aplasia and skin biopsy was consistent with GVHD. Allele-level HLA typing on circulating lymphocytes revealed extra HLA alleles not present in patient's pretreatment sample, but identical to the HLA haplotypes of an unrelated platelet donor. Non-leukocyte reduced, non-irradiated platelet from donor who was a previous platelet transfusion donor (90 days previously).
Suggest new keywords:
Leitman S.F., Tisdale, J.F., Bolan, C.D., Popovshky, M.A., Liippel, J.H., Balow, J.E., Boumpas, D.T. and Illei, G.G. (2003). Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 43(12):1667-71.